Skip to main content
Menu
US

IVISense Cat B 750 FAST Fluorescent Probe

IVISense Cat B FAST fluroescent probes enable non-invasive in vivo detection of disease status and progression in oncology, inflammation and other areas associated with Cat B activity.

Associated with tumor aggression, cathepsins are a family of proteases that are pivotal components of signaling pathways that can enhance cancer cell growth and inflammation. Within the human lysosomal cysteine cathepsin family, there are 11 members, including cathepsin B, L, S, and Plasmin. As a family, cysteine cathepsins are involved in the response to anticancer therapy within the tumor microenvironment and play crucial roles in the development of resistance to therapeutics. In particular, cathepsin B expression correlates with the invasive and metastatic capabilities of many tumors, such as in breast cancer where high expression levels of cathepsin B have been linked to highly aggressive tumors. Cathepsin B is also upregulated in a variety of inflammatory cells (including eosinophils, neutrophils, and macrophages).

For research use only. Not for use in diagnostic procedures.

Product Variants
Part number: NEV11112
Wave Length: 680 nm
List price: USD 709.32
Your price:
USD 0.00
USD 709.32 /each
Part number: NEV11098
Wave Length: 750 nm
List price: USD 688.64
Your price:
USD 688.64
USD 688.64 /each

Overview

IVISense Cat B 750 FAST is a Cathepsin B activatable fluorescent probe that is optically silent upon injection and produces fluorescent signal after cleavage by Cathepsin B produced by inflammatory cells and tumor cells. IVISense Cat B 750 FAST may be used to monitor inflammation, tumor activity, progression of disease and the efficacy of therapeutic treatment in applications such as oncology, inflammation, cardiovascular disease and some neurological diseases.

IVISense Cat B 750 FAST is a member of a family of activatable fluorescent imaging agents comprising a novel architecture, termed F.A.S.T. (Fluorescent Activatable Sensor Technology) that confers an improved pharmacokinetic profile with a broader range of early imaging time points. This architecture also offers higher target specific signal with reduced background.

Specifications

Brand
IVISense
Fluorescent Agent Type
Activatable
Optical Imaging Classification
Fluorescence Imaging
Quantity in a Package Amount
1.0 Units
Shipping Conditions
Shipped Ambient
Therapeutic Area
Arthritis
Atherosclerosis
Inflammation
Oncology/Cancer
Unit Size
1 Vial (10 doses)
Wave Length
750 nm

Resources

1-1 of 1 Resources
eBook Icon
eBook
In vivo imaging solutions

Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...

SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon